Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opium tincture for control of methamphetamine-associated clinical signs
IRCT2015080223470N1Phase 3Completed
- Sponsor
- University of Medical Sciences
- Start
- Sep 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of opium tincture in methamphetamine use disorder (MUD), sponsored by University of Medical Sciences. Started Sep 2015; status: completed.
02
Drugs
opium tincture
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on IRCT2015080223470N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015080223470N1.